Cited by 1,492Cancer Genomics and DiagnosticsColorectal Cancer Treatments and StudiesGenetic factors in colorectal cancer

The DOI matches its Crossref record; 41 of the 43 references it cites were found in a registry or an index.

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Open access

Tie, Jeanne, Wang, Yuxuan, Tomasetti, Cristian, Li, Lu, Springer, Simeon, Kinde, Isaac, Silliman, Natalie, Tacey, Mark, Wong, Hui-Li, Christie, Michael, Kosmider, Suzanne, Skinner, Iain, Wong, Rachel, Steel, Malcolm, Tran, Ben, Desai, Jayesh, Jones, Ian, Haydon, Andrew, Hayes, Theresa, Price, Tim J., Strausberg, Robert L., Diaz, Luis A., Papadopoulos, Nickolas, Kinzler, Kenneth W., Vogelstein, Bert, Gibbs, Peter·2016·Science Translational Medicine

DOI 10.1126/scitranslmed.aaf6219PMC PMC5346159

Open this paper in CoChat — free account

Abstract

Detection of circulating tumor DNA in patients with resected stage II colon cancer provides evidence of residual disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaf6219

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citation
Time‐Dependent ROC Curves for Censored Survival Data and a Diagnostic Marker
Heagerty, P. J., Lumley, T., & PEPE, M. S. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00337.x · Cited by 2,870
The Genomic Landscapes of Human Breast and Colorectal Cancers
Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjöblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J., et al. (2007) · Science · doi:10.1126/science.1145720 · Cited by 2,833
Self-citation
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746
Self-citation
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
Misale, S., Yaeger, R., Hobor, S., Scala, E., Janakiraman, M., Liska, D., Valtorta, E., Schiavo, R., Buscarino, M., Siravegna, G., et al. (2012) · Nature · doi:10.1038/nature11156 · Cited by 1,889
The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers
Diaz Jr, L. A., Williams, R. T., Wu, J., Kinde, I., Hecht, J. R., Berlin, J., Allen, B., Bozic, I., Reiter, J. G., Nowak, M. A., et al. (2012) · Nature · doi:10.1038/nature11219 · Cited by 1,713
Self-citation
Defective Mismatch Repair As a Predictive Marker for Lack of Efficacy of Fluorouracil-Based Adjuvant Therapy in Colon Cancer
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623

Flagged first, then by citations

Show all 43 references

2 of the 43 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

S. Edge D. R. Byrd C. C. Compton A. G. Fritz F. L. Greene A. Trotti AJCC Cancer Staging Manual (Springer New York 2010) 648 pp.

Sorted by citations

Items 101–200 of 1,001

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
Tie, J., Wang, Y., Cohen, J. D., Li, L., Hong, W., Christie, M., Wong, H., Kosmider, S., Wong, R., Thomson, B. N. J., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003620 · Cited by 189
Self-citation
Detection of Solid Tumor Molecular Residual Disease (MRD) Using Circulating Tumor DNA (ctDNA)
Chin, R.-I., Chen, K., Usmani, A., Chua, C., Harris, P. K., Binkley, M. S., Azad, T. D., Dudley, J. C., & Chaudhuri, A. A. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00390-5 · Cited by 191
Monitoring Treatment Response and Metastatic Relapse in Advanced Bladder Cancer by Liquid Biopsy Analysis
Birkenkamp‐Demtröder, K., Christensen, E., Nordentoft, I., Knudsen, M., Taber, A., Høyer, S., Lamy, P., Agerbæk, M., Jensen, J. B., & Dyrskjøt, L. (2017) · European Urology · doi:10.1016/j.eururo.2017.09.011 · Cited by 179
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
Stadler, J.-C., Belloum, Y., Deitert, B., Sementsov, M., Heidrich, I., Gebhardt, C., Keller, L., & Pantel, K. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-1718 · Cited by 190
Enhanced specificity of clinical high-sensitivity tumor mutation profiling in cell-free DNA via paired normal sequencing using MSK-ACCESS
Brannon, A. R., Jayakumaran, G., Diosdado, M. S., Patel, J., Razumova, A., Hu, Y., Meng, F., Haque, M., Sadowska, J., Murphy, B. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24109-5 · Cited by 177
Self-citation
Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
Jia, S., Zhang, R., Li, Z., & Li, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17184 · Cited by 175
Sequencing-based counting and size profiling of plasma Epstein–Barr virus DNA enhance population screening of nasopharyngeal carcinoma
Lam, W. K., Jiang, P., Chan, K. C. A., Cheng, S. H., Zhang, H., Peng, W., Tse, O. Y. O., Tong, Y. K., Gai, W., Zee, B. C.-Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804184115 · Cited by 173
The effect of surgical trauma on circulating free DNA levels in cancer patients—implications for studies of circulating tumor DNA
Henriksen, T. V., Reinert, T., Christensen, E., Sethi, H., Birkenkamp‐Demtröder, K., Gögenur, M., Gögenür, I., Zimmermann, B. G., The IMPROVE Study Group, Dyrskjøt, L., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12729 · Cited by 171
The Developing Story of Predictive Biomarkers in Colorectal Cancer
Boussios, S., Öztürk, M. A., Moschetta, M., Karathanasi, A., Zakynthinakis-Kyriakou, N., Katsanos, K. H., Christodoulou, D. K., & Pavlidis, N. A. (2019) · Journal of Personalized Medicine · doi:10.3390/jpm9010012 · Cited by 172
Circulating Tumor DNA Reveals Clinically Actionable Somatic Genome of Metastatic Bladder Cancer
Vandekerkhove, G. R., Todenhöfer, T., Annala, M., Struss, W. J., Wong, A., Beja, K., Ritch, E. J., Brahmbhatt, S., Volik, S. V., Hennenlotter, J., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1140 · Cited by 168
The potential of liquid biopsies for the early detection of cancer
Heitzer, E., Perakis, S. O., Geigl, J. B., & Speicher, M. R. (2017) · npj Precision Oncology · doi:10.1038/s41698-017-0039-5 · Cited by 170
Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma
Kannarkatt, J., Joseph, J. P., Kurniali, P. C., Al-Janadi, A., & Hrinczenko, B. W. (2017) · Journal of Oncology Practice · doi:10.1200/jop.2016.017210 · Cited by 162
Circulating tumor DNA predicts survival in patients with resected high-risk stage II/III melanoma
Lee, R. J., Gremel, G., Marshall, A., Myers, K. A., Fisher, N., Dunn, J., Dhomen, N. S., Corrie, P. G., Middleton, M. R., Lorigan, P. C., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx717 · Cited by 170
Comprehensive Liquid Profiling of Circulating Tumor DNA and Protein Biomarkers in Long-Term Follow-Up Patients with Hepatocellular Carcinoma
Cai, Z., Chen, G., Zeng, Y., Dong, X., Li, Z., Huang, Y., Xin, F., Qiu, L., Xu, H., Zhang, W. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3477 · Cited by 164
Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study
Wang, Y., Yang, L., Bao, H., Fan, X., Xia, F., Wan, J., Shen, L., Guan, Y., Bao, H., Wu, X., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003741 · Cited by 166
Self-citation
Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
Peng, Y., Mei, W., Ma, K., & Zeng, C. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.763790 · Cited by 167
Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy
Auclin, É., Zaanan, A., Vernerey, D., Douard, R., Gallois, C., Laurent‐Puig, P., Bonnetain, F., & Taı̈eb, J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx030 · Cited by 159
Novel SERS labels: Rational design, functional integration and biomedical applications
Shan, B., Pu, Y., Chen, Y., Liao, M., & Li, M. (2018) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.05.007 · Cited by 161
Clinical utility of circulating tumor DNA for colorectal cancer
Osumi, H., Shinozaki, E., Yamaguchi, K., & Zembutsu, H. (2019) · Cancer Science · doi:10.1111/cas.13972 · Cited by 153
Autoantibodies in Rheumatoid Arthritis: Historical Background and Novel Findings
Sokolova, M. V., Schett, G. A., & Steffen, U. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08890-1 · Cited by 166
The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios
Normanno, N., Cervantes, A. M. R., Ciardiello, F., Luca, A. D., & Pinto, C. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.07.007 · Cited by 152
Longitudinal Cell-Free DNA Analysis in Patients with Small Cell Lung Cancer Reveals Dynamic Insights into Treatment Efficacy and Disease Relapse
Almodovar, K., Iams, W. T., Meador, C. B., Zhao, Z., York, S. J., Horn, L., Yan, Y., Hernandez, J., Chen, H., Shyr, Y., et al. (2017) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2017.09.1951 · Cited by 145
Molecular Diagnostics in Clinical Oncology
Соколенко, А. П., & Имянитов, Е. Н. (2018) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00076 · Cited by 151
Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics
Geeurickx, E., & Hendrix, A. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.10.005 · Cited by 150
Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
Chakrabarti, S., Peterson, C. Y., Sriram, D., & Mahipal, A. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i8.808 · Cited by 151
Circulating tumor DNA analysis guiding adjuvant therapy in stage II colon cancer: 5-year outcomes of the randomized DYNAMIC trial
Tie, J., Wang, Y., Lo, S., Lahouel, K., Cohen, J. D., Wong, R., Shapiro, J. D., Harris, S. J., Khattak, A., Burge, M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03579-w · Cited by 159
Self-citation
Serial Circulating Tumor DNA in Predicting and Monitoring the Effect of Neoadjuvant Chemoradiotherapy in Patients with Rectal Cancer: A Prospective Multicenter Study
Zhou, J., Wang, C., Lin, G., Xiao, Y., Jia, W., Xiao, G., Liu, Q., Wu, B., Wu, A., Qiu, H., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2299 · Cited by 141
Liquid biopsy in the clinical management of hepatocellular carcinoma
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020) · Gut · doi:10.1136/gutjnl-2019-320282 · Cited by 141
Detection of Somatic Structural Variants Enables Quantification and Characterization of Circulating Tumor DNA in Children With Solid Tumors
Klega, K. S., Imamović, A., Ha, G., Clapp, A. N., Meyer, S. C., Ward, A., Clinton, C., Nag, A., Allen, E. M. V., Mullen, E. A., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00285 · Cited by 142
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
Chae, Y. K., & Oh, M. S. (2018) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2018.09.022 · Cited by 142
MRI Tumor Regression Grade and Circulating Tumor DNA as Complementary Tools to Assess Response and Guide Therapy Adaptation in Rectal Cancer
Khakoo, S. S., Carter, P. D., Brown, G. M., Valeri, N., Picchia, S., Bali, M. A., Shaikh, R., Jones, T., Begum, R., Rana, I., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1996 · Cited by 135
Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment
Widman, A. J., Shah, M. J., Frydendahl, A., Halmos, D., Khamnei, C. C., Øgaard, N., Rajagopalan, S., Arora, A., Deshpande, A. S., Hooper, W. F., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03040-4 · Cited by 148
Liquid Biopsy in Head and Neck Cancer: Promises and Challenges
Nonaka, T., & Wong, D. T. (2018) · Journal of Dental Research · doi:10.1177/0022034518762071 · Cited by 140
Serial ctDNA Monitoring to Predict Response to Systemic Therapy in Metastatic Gastrointestinal Cancers
Parikh, A. R., Mojtahed, A., Schneider, J. L., Kanter, K. N., Seventer, E. E. V., Fetter, I. J., Thabet, A., Fish, M. G., Teshome, B., Fosbenner, K. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3467 · Cited by 142
Liquid Biopsies, Novel Approaches and Future Directions
Armakolas, A., Kotsari, M., & Koskinas, J. S. (2023) · Cancers · doi:10.3390/cancers15051579 · Cited by 141
Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Kato, S., Okamura, R., Baumgartner, J. M., Patel, H., Leichman, L., Kelly, K. J., Sicklick, J. K., Fanta, P. T., Lippman, S. M., & Kurzrock, R. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1128 · Cited by 129
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
Guibert, N. M., Pradines, A., Favre, G., & Mazières, J. (2020) · European Respiratory Review · doi:10.1183/16000617.0052-2019 · Cited by 135
Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation
Mo, S., Li, Y., Wang, D., Han, L., Zhou, S., Wang, H., Dai, W., Wang, Y., Luo, W., Wang, R., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.0425 · Cited by 135
Self-citation
Precancer Atlas to Drive Precision Prevention Trials
Spira, A. E., Yurgelun, M. B. B., Alexandrov, L. B., Rao, A., Bejar, R., Polyák, K., Giannakis, M., Shilatifard, A., Finn, O. J., Dhodapkar, M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2346 · Cited by 134
Liquid biopsy in gliomas: A RANO review and proposals for clinical applications
Soffietti, R., Bettegowda, C., Mellinghoff, I. K., Warren, K. E., Ahluwalia, M. S., de Groot, J., Galanis, E., Gilbert, M. R., Jaeckle, K. A., Rhun, É. L., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac004 · Cited by 132
The potential of liquid biopsy in the management of cancer patients
Markou, A. N., Tzanikou, E., & Lianidou, E. S. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.013 · Cited by 129
The value of cell‐free DNA for molecular pathology
Stewart, C. M., Kothari, P. D., Mouliere, F. C., Mair, R. J., Somnay, S., Benayed, R., Zehir, A., Weigelt, B., Dawson, S., Arcila, M. E., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5048 · Cited by 129
The kinase polypharmacology landscape of clinical PARP inhibitors
Antolín, A. A., Ameratunga, M., Banerji, U., Clarke, P. A., Workman, P., & Al‐Lazikani, B. (2020) · Scientific Reports · doi:10.1038/s41598-020-59074-4 · Cited by 137
Personalizing adjuvant therapy for patients with colorectal cancer
Yang, L., Yang, J., Kleppe, A., Danielsen, H. E., & Kerr, D. J. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00834-2 · Cited by 126
Liquid Biopsy in Clinical Management of Breast, Lung, and Colorectal Cancer
Hench, I. B., Hench, J., & Tolnay, M. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00009 · Cited by 126
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
García-Pardo, M., Makarem, M., Li, J. J. N., Kelly, D., & Leighl, N. B. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01776-9 · Cited by 121
Circulating tumour DNA (CtDNA) as a liquid biopsy for melanoma
Calapre, L., Warburton, L., Millward, M., Ziman, M., & Gray, E. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.06.030 · Cited by 118
Liquid BIOpsy for MiNimal RESidual DiSease Detection in Head and Neck Squamous Cell Carcinoma (LIONESS)—a personalised circulating tumour DNA analysis in head and neck squamous cell carcinoma
Flach, S., Howarth, K., Hackinger, S., Pipinikas, C., Ellis, P., McLay, K., Marsico, G., Forshew, T., Walz, C., Reichel, C. A., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01716-7 · Cited by 119
Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?
Buono, G., Gerratana, L., Bulfoni, M., Provinciali, N., Basile, D., Giuliano, M., Corvaja, C., Arpino, G., Mastro, L. D., Placido, S. D., et al. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.01.004 · Cited by 117
Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
Bidard, F., Kiavué, N., Ychou, M., Cabel, L., Stern, M., Madic, J., Saliou, A., Rampanou, A., Decraene, C., Bouché, O., et al. (2019) · Cells · doi:10.3390/cells8060516 · Cited by 116
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
Labgaa, I., Villacorta-Martín, C., D’Avola, D., Craig, A. J., von Felden, J., Martins-Filho, S. N., Sia, D., Stueck, A., Ward, S. C., Fiel, M. I., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0206-3 · Cited by 117
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives
Taı̈eb, J., André, T., & Auclin, É. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.02.002 · Cited by 115
Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer
Peng, M., Huang, Q., Yin, W., Tan, S., Chen, C., Liu, W., Tang, J., Wang, X., Zhang, B., Zou, M., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.561598 · Cited by 116
Prognostic significance of postsurgery circulating tumor DNA in nonmetastatic colorectal cancer: Individual patient pooled analysis of three cohort studies
Tie, J., Cohen, J. D., Lo, S., Wang, Y., Li, L., Christie, M., Lee, M., Wong, R., Kosmider, S., Skinner, I., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33312 · Cited by 113
Self-citation
A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma
Jones, G. D., Brandt, W. S., Shen, R., Sánchez-Vega, F., Tan, K. S., Martin, A. S., Zhou, J. H., Berger, M. F., Solit, D. B., Schultz, N. D., et al. (2020) · JAMA Surgery · doi:10.1001/jamasurg.2020.5601 · Cited by 116
Integrated approaches for precision oncology in colorectal cancer: The more you know, the better
Andrei, P., Battuello, P., Grasso, G., Rovera, E., Tesio, N., & Bardelli, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.007 · Cited by 116
Circulating cell-free DNA for non-invasive cancer management
Stewart, C. M., & Tsui, D. W. Y. (2018) · Cancer Genetics · doi:10.1016/j.cancergen.2018.02.005 · Cited by 109
Longitudinal tracking of 97 esophageal adenocarcinomas using liquid biopsy sampling
Ococks, E., Frankell, A. M., Masqué‐Soler, N., Grehan, N., Northrop, A., Coles, H., Redmond, A. M., Devonshire, G., Weaver, J. M. J., Hughes, C. D., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2020.12.010 · Cited by 114
Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy
Chan, H. T., Nagayama, S., Chin, Y. M., Otaki, M., Hayashi, R., Kiyotani, K., Fukunaga, Y., Ueno, M., Nakamura, Y., & Low, S. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12727 · Cited by 110
Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing
Dharajiya, N. G., Grosu, D. S., Farkas, D. H., McCullough, R. M., Almasri, E., Sun, Y., Kim, S. K., Jensen, T. J., Saldivar, J., Topol, E. J., et al. (2017) · Clinical Chemistry · doi:10.1373/clinchem.2017.277517 · Cited by 109
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
Strijker, M., Soer, E. C., Pastena, M. D., Creemers, A., Balduzzi, A., Beagan, J. J., Busch, O. R., van Delden, O. M., Halfwerk, H., van Hooft, J. E., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32586 · Cited by 107
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort
Written on behalf of AME Lung Cancer Collaborative Group, Song, Y., Hu, C., Xie, Z., Wu, L., Zhu, Z., Rao, C., Liu, L., Chen, Y., Liang, N., et al. (2020) · Translational Lung Cancer Research · doi:10.21037/tlcr.2020.03.17 · Cited by 109
Circulating HPV DNA as a Marker for Early Detection of Relapse in Patients with Cervical Cancer
Jeannot, E., Latouche, A., Bonneau, C., Calméjane, M.-A., Beaufort, C. M., Ruigrok-Ritstier, K., Bataillon, G., Chérif, L. L., Dupain, C., Lecerf, C., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0625 · Cited by 108
A clinician’s handbook for using ctDNA throughout the patient journey
Hasenleithner, S. O., & Speicher, M. R. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01551-7 · Cited by 110
Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer
Baassiri, A., Nassar, F. J., Mukherji, D., Shamseddine, A. I., Nasr, R., & Temraz, S. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041398 · Cited by 110
Serial circulating tumour DNA analysis for locally advanced rectal cancer treated with preoperative therapy: prediction of pathological response and postoperative recurrence
Murahashi, S., Akiyoshi, T., Sano, T., Fukunaga, Y., Noda, T., Ueno, M., & Zembutsu, H. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0941-4 · Cited by 106
The molecular profiling of solid tumors by liquid biopsy: a position paper of the AIOM–SIAPEC-IAP–SIBioC–SIC–SIF Italian Scientific Societies
Russo, A. D., Incorvaia, L., Re, M. D., Malapelle, U., Capoluongo, E., Gristina, V., Castiglia, M., Danesi, R., Fassan, M., Giuffrè, G., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100164 · Cited by 106
Efficient detection and post-surgical monitoring of colon cancer with a multi-marker DNA methylation liquid biopsy
Jin, S., Zhu, D., Shao, F., Chen, S., Guo, Y., Li, K., Wang, Y., Ding, R., Gao, L., Ma, W., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017421118 · Cited by 109
Self-citation
Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
Vymetalkova, V. P., Červená, K., Bartu, L., & Vodička, P. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113356 · Cited by 109
Prognostic value of ctDNA detection in patients with early breast cancer undergoing neoadjuvant therapy: A systematic review and meta-analysis
Papakonstantinou, A., Gonzalez, N. S., Pimentel, I., Suñol, A., Zamora, E., Ortiz, C., Espinosa-Bravo, M., Peg, V., Vivancos, A. P., Saura, C., et al. (2022) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2022.102362 · Cited by 108
Using cfDNA and ctDNA as Oncologic Markers: A Path to Clinical Validation
Dao, J., Conway, P., Subramani, B., Meyyappan, D., Russell, S., & Mahadevan, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713219 · Cited by 112
Advances in liquid biopsy approaches for early detection and monitoring of cancer
Babayan, A., & Pantel, K. (2018) · Genome Medicine · doi:10.1186/s13073-018-0533-6 · Cited by 104
Generic Protocols for the Analytical Validation of Next-Generation Sequencing-Based ctDNA Assays: A Joint Consensus Recommendation of the BloodPAC’s Analytical Variables Working Group
Godsey, J. H., Silvestro, A., Barrett, J. C., Bramlett, K., Chudova, D., Deras, I., Dickey, J., Hicks, J., Johann, D. J., Leary, R., et al. (2020) · Clinical Chemistry · doi:10.1093/clinchem/hvaa164 · Cited by 104
Circulating tumor DNA analyses predict progressive disease and indicate trastuzumab-resistant mechanism in advanced gastric cancer
Wang, Y., Zhao, C., Chang, L., Jia, R., Liu, R., Zhang, Y., Gao, X., Li, J., Chen, R., Xia, X., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.04.003 · Cited by 101
Self-citation
Prognostic Value and Relation with Adjuvant Treatment Duration of ctDNA in Stage III Colon Cancer: a Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France Trial
Taı̈eb, J., Taly, V., Henriques, J., Bourreau, C., Mineur, L., Bennouna, J., Desrame, J., Louvet, C., Lepère, C., Mabro, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0271 · Cited by 107
Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring
Kang, Z., Stevanović, S., Hinrichs, C. S., & Cao, L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1553 · Cited by 105
Prognostic Impact of Residual HPV ctDNA Detection after Chemoradiotherapy for Anal Squamous Cell Carcinoma
Cabel, L., Jeannot, E., Bièche, I., Vacher, S., Callens, C., Bazire, L., Morel, A., Bernard‐Tessier, A., Chemlali, W., Schnitzler, A., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0922 · Cited by 102
Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non–small cell lung cancer
Li, N., Wang, B.-X., Li, J., Shao, Y. W., Li, M., Li, J., Kuang, P., Liu, Z., Sun, T., Wu, H.-Q., et al. (2021) · Cancer · doi:10.1002/cncr.33985 · Cited by 104
Liquid biopsies to monitor and direct cancer treatment in colorectal cancer
Mauri, G., Vitiello, P. P., Sogari, A., Crisafulli, G., Bianchi, A. S., Marsoni, S., Siena, S., & Bardelli, A. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-01769-8 · Cited by 108
Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNA
Semenkovich, N. P., Szymanski, J. J., Earland, N. J., Chauhan, P. S., Pellini, B., & Chaudhuri, A. A. (2023) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-006284 · Cited by 111
The Prognostic and Therapeutic Role of Genomic Subtyping by Sequencing Tumor or Cell-Free DNA in Pulmonary Large-Cell Neuroendocrine Carcinoma
Zhuo, M., Guan, Y., Yang, X., Hong, L., Wang, Y., Li, Z., Chen, R., Abbas, H. A., Chang, L., Gong, Y., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0556 · Cited by 99
Self-citation
Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
Kasi, P. M., Fehringer, G., Taniguchi, H., Starling, N., Nakamura, Y., Kotani, D., Powles, T. B., Li, B. T., Pusztai, L., Aushev, V. N., et al. (2022) · JCO Precision Oncology · doi:10.1200/po.21.00181 · Cited by 103
Incorporating blood-based liquid biopsy information into cancer staging: time for a TNMB system?
Yang, M., Forbes, M. E., Bitting, R. L., O’Neill, S. S., Chou, P. C., Topaloĝlu, Ü., Miller, L. D., Hawkins, G. A., Grant, S. C., DeYoung, B. R., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx766 · Cited by 99
Clinical Impact of Presurgery Circulating Tumor DNA after Total Neoadjuvant Treatment in Locally Advanced Rectal Cancer: A Biomarker Study from the GEMCAD 1402 Trial
Vidal, J., Casadevall, D., Bellosillo, B., Pericay, C., García‐Carbonero, R., Losa, F., Layos, L., Alonso, V., Capdevila, J., Gallego-Plazas, J., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4769 · Cited by 96
Making sense of adjuvant chemotherapy in colorectal cancer
Chan, G. H. J., & Chee, C. E. (2019) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2019.06.03 · Cited by 82
Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the Challenges
Kranenburg, O., der Speeten, K. V., & de Hingh, I. H. J. T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.650098 · Cited by 99
Noninvasive Biomarkers of Colorectal Cancer: Role in Diagnosis and Personalised Treatment Perspectives
Pellino, G., Gallo, G., Pallante, P., Capasso, R., Stefano, A. D., Maretto, I., Malapelle, U., Qiu, S., Nikolaou, S., Barina, A., et al. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/2397863 · Cited by 96
Neoadjuvant treatment of colorectal cancer: comprehensive review
Smith, H. G., Nilsson, P. J., Shogan, B. D., Harji, D. P., Gambacorta, M. A., Romano, Â., Brandl, A., & Qvortrup, C. (2024) · BJS Open · doi:10.1093/bjsopen/zrae038 · Cited by 103
Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow
Mazzotti, C., Buisson, L., Mahéo, S., Perrot, A., Chrétien, M., Leleu, X. P., Hulin, C., Manier, S., Hébraud, B., Roussel, M., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018025197 · Cited by 92
The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
Reece, M. M., Saluja, H., Hollington, P., Karapetis, C. S., Vatandoust, S., Young, G. P., & Symonds, E. L. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.01118 · Cited by 95
Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study
Lv, J., Xu, L.-X., Li, Z., Lin, L. C., Wu, C., Quan, T.-Q., Zhen, Z.-C., Li, W., Tang, L., Mao, Y., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.07.001 · Cited by 92
Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients
Jensen, T. J., Goodman, A. M., Kato, S., Ellison, C. K., Daniels, G. A., Kim, L., Nakashe, P., McCarthy, E., Mazloom, A. R., McLennan, G., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0535 · Cited by 90
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
Tie, J., Wang, Y., Loree, J. M., Cohen, J. D., Wong, R., Price, T. J., Tebbutt, N. C., Gebski, V., Espinoza, D., Burge, M., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-04030-w · Cited by 105
Self-citation
Next-generation sequencing in cancer diagnosis and treatment: clinical applications and future directions
Ghoreyshi, N., Heidari, R., Farhadi, A., Chamanara, M., Farahani, N., Vahidi, M., & Behroozi, J. (2025) · Discover Oncology · doi:10.1007/s12672-025-01816-9 · Cited by 91
Recent advances in circulating nucleic acids in oncology
Otandault, A., Anker, P., Dache, Z. A. A., Guillaumon, V., Meddeb, R., Pastor, B., Pisareva, E., Sánchez, C., Tanos, R., Tousch, G., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz031 · Cited by 94
Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
Zhu, G., Guo, Y. A., Ho, D., Poon, P. S. Y., Poh, Z. W., Wong, P., Gan, A., Chang, M. M., Kleftogiannis, D., Lau, Y. T., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22463-y · Cited by 90
Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
Lawler, M., Alsina, D., Adams, R., Anderson, A. S., Brown, G. M., Fearnhead, N. S., Fenwick, S. W., Halloran, S. P., Hochhauser, D., Hull, M. A., et al. (2017) · Gut · doi:10.1136/gutjnl-2017-315333 · Cited by 91
Detection of low-frequency DNA variants by targeted sequencing of the Watson and Crick strands
Cohen, J. D., Douville, C. B., Dudley, J. C., Mog, B. J., Popoli, M., Ptak, J., Dobbyn, L., Silliman, N., Schaefer, J., Tie, J., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00900-z · Cited by 88
Self-citation
Low-pass Whole-genome Sequencing of Circulating Cell-free DNA Demonstrates Dynamic Changes in Genomic Copy Number in a Squamous Lung Cancer Clinical Cohort
Chen, X., Chang, C., Spoerke, J. M., Yoh, K. E., Kapoor, V., Baudo, C. D., Aimi, J., Yu, M., Liang-Chu, M. M. Y., Suttmann, R., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1593 · Cited by 90
Circulating Tumor DNA in Precision Oncology and Its Applications in Colorectal Cancer
Arisi, M. F., Dotan, E., & Fernandez, S. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084441 · Cited by 89

Authors: Tie, J., Wang, Y., Tomasetti, C., Li, L., Springer, S., Kinde, I., Silliman, N., Tacey, M., Wong, H.-L., Christie, M., Kosmider, S., Skinner, I., Wong, R., Steel, M., Tran, B., Desai, J., Jones, I., Haydon, A., Hayes, T., Price, T. J., Strausberg, R. L., Diaz, L. A., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., & Gibbs, P.
Affiliations: The University of Melbourne (AU)
Howard Hughes Medical Institute (US)
Johns Hopkins University (US)
PapGene (United States) (US)
The Royal Melbourne Hospital (AU)
Western Health (AU)
Walter and Eliza Hall Institute of Medical Research (AU)
Eastern Health (AU)
The Alfred Hospital (AU)
Department of Medical Oncology, Warrnambool Hospital, Warrnambool, Victoria 3280, Australia.
Department of Medical Oncology, Queen Elizabeth Hospital and University of Adelaide, Adelaide, South Australia 3174, Australia.
Ludwig Cancer Research (US)
Corresponding author: Tie, Jeanne
Wang, Yuxuan
Vogelstein, Bert
Gibbs, Peter
ORCID: Tie, Jeanne
Wang, Yuxuan
Tomasetti, Cristian
Li, Lu
Springer, Simeon
Silliman, Natalie
Tacey, Mark
Wong, Hui-Li
Christie, Michael
Kosmider, Suzanne
Skinner, Iain
Wong, Rachel
Steel, Malcolm
Tran, Ben
Desai, Jayesh
Jones, Ian
Haydon, Andrew
Hayes, Theresa
Diaz, Luis A.
Papadopoulos, Nickolas
Kinzler, Kenneth W.
Vogelstein, Bert
Gibbs, Peter
Venue: Science Translational Medicine
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2016-07-06
Volume: 8
Issue: 346
Pages: 346ra92-346ra92
ISSN: 1946-6234 (ISSN-L)
1946-6242
DOI: 10.1126/scitranslmed.aaf6219
PMC: PMC5346159
OpenAlex: W2460179076
Cited by: 1,492
References: 43
Citations by year: 2026: 119 · 2025: 131 · 2024: 130 · 2023: 181 · 2022: 173 · 2021: 197 · 2020: 173 · 2019: 146 · 2018: 134 · 2017: 90 · 2016: 14
FWCI: 53.29
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.sciencemag.org/about/science-licenses-journal-article-reuse (vor, 365 d)
Locations: Science Translational Medicine (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Funders: Virginia and D.K. Ludwig Fund for Cancer Research
Conrad N. Hilton Foundation
Sol Goldman Sequencing Facility at Johns Hopkins
NIH (CA57345, R37-CA43460, U01-CA152753, P30-CA006973)
Victorian Cancer Agency
Victorian Cancer Agency Clinical Research Fellowship
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords: circulating tumor DNA, stage II colon cancer, minimal residual disease, tumor recurrence prediction, adjuvant chemotherapy, liquid biopsy, recurrence-free survival, plasma biomarkers, resected colon cancer
MeSH terms: Circulating Tumor DNA, Colonic Neoplasms, Humans, Neoplasm Recurrence, Local, Neoplasm Staging, Prospective Studies, Proportional Hazards Models, Neoplasm, Residual, Disease-Free Survival

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks